PeraMobile and PeraWatch vs Sepsis ImmunoScore

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
PeraMobile and PeraWatch
by PeraHealth (acquired by Spacelabs Healthcare)
VS
Sepsis ImmunoScore
by Prenosis

AI Verdict

These tools are adjacent competitors, both providing clinical decision support for patient risk assessment. PeraMobile and PeraWatch offer a general solution for real-time patient acuity scoring and deterioration prediction across various conditions, leveraging the Rothman Index. In contrast, Sepsis ImmunoScore is a specialized AI diagnostic specifically for sepsis, focusing on rapid risk assessment and prediction of adverse outcomes related to this critical condition.

Choose PeraMobile and PeraWatch if…

Choose PeraMobile and PeraWatch if your organization requires a comprehensive, system-wide solution for real-time patient acuity monitoring and early detection of general patient deterioration across various conditions. This tool is ideal for enabling proactive intervention and providing clinicians with mobile access to critical patient insights, improving overall quality and reducing costs.

View PeraMobile and PeraWatch →

Choose Sepsis ImmunoScore if…

Choose Sepsis ImmunoScore if your primary focus is on rapidly and accurately diagnosing sepsis and predicting adverse outcomes using the first FDA-authorized AI diagnostic specifically for sepsis. This tool is designed for acute care settings where precise, data-driven insights into sepsis risk are critical for guiding faster treatment decisions and improving patient-specific sepsis management.

View Sepsis ImmunoScore →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature PeraMobile and PeraWatch Sepsis ImmunoScore
Pricing Contact for pricing Enterprise subscription model
Deployment Software-only, integrated with EHRs, web-based access, mobile application, on user-provided hardware. Integrated into hospital EHR/EMR systems
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PeraMobile and PeraWatch

Tool A, PeraMobile, explicitly highlights 'Mobile access for on-the-go clinicians' and 'Visual dashboards of patient condition trends (PeraTrend)', suggesting a strong focus on flexible and intuitive access across various clinical settings. While Tool B emphasizes an 'intuitive display' and transparency, Tool A's broader accessibility via mobile applications and configurable notifications likely offers a more versatile and user-friendly experience for diverse clinical workflows.

Clinical Value

Sepsis ImmunoScore

Tool B, Sepsis ImmunoScore, is the 'first FDA-authorized AI diagnostic for sepsis' and provides rapid risk assessment and prediction of specific adverse outcomes like mortality, ICU admission, and length of stay within 24 hours. This highly targeted diagnostic and predictive capability for a critical condition offers a more distinct and measurable clinical advantage compared to Tool A's general patient acuity scoring and deterioration prediction.

Pricing & Value

Tie

Both tools operate on an enterprise subscription model with pricing that is not publicly disclosed and varies by client. Without transparent pricing details or specific return-on-investment metrics from either vendor, it is impossible to conduct a meaningful head-to-head comparison on this dimension.

Enterprise Readiness

Sepsis ImmunoScore

Tool B explicitly confirms HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are fundamental requirements for enterprise healthcare deployments. Its exclusive distribution partnership with Roche Diagnostics also suggests a robust sales, implementation, and support infrastructure, further enhancing its readiness for large-scale hospital integration.

Innovation

Sepsis ImmunoScore

Tool B, Sepsis ImmunoScore, stands out as the 'first FDA-authorized AI diagnostic for sepsis' and leverages AI/ML as a Software as a Medical Device (SaMD) by analyzing 22 diverse parameters for precise risk prediction. This represents a significant advancement in diagnostic AI for a critical condition, offering a higher degree of innovation compared to Tool A's more general predictive analytics.

Support & Docs

Tie

The provided structured facts and web search results do not offer specific details regarding the support services or documentation available for either PeraMobile/PeraWatch or Sepsis ImmunoScore. Therefore, without this crucial information, it is not possible to differentiate between the two tools in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature PeraMobile and PeraWatch Sepsis ImmunoScore
Tool Name PeraMobile and PeraWatch Sepsis ImmunoScore
Company PeraHealth (acquired by Spacelabs Healthcare) Prenosis
Key Focus Predictive analytics for patient deterioration (Rothman Index) AI diagnostic for sepsis, rapid risk assessment and prediction of adverse outcomes
Categories Clinical Decision Support & Reference, Population Health Analytics, Triage & ER/ICU AI Clinical Decision Support & Reference, Triage & ER/ICU AI
Specialties Critical Care, Emergency Medicine, Hospital Medicine Critical Care, Emergency Medicine, Hospital Medicine

Videos

Demos, reviews, and walkthroughs featuring PeraMobile and PeraWatch and Sepsis ImmunoScore.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

PeraMobile and PeraWatch are designed for general patient deterioration, helping healthcare providers identify at-risk patients sooner for earlier intervention. Sepsis ImmunoScore, on the other hand, is specifically focused on sepsis, providing rapid risk assessment and prediction of adverse outcomes related to sepsis.
PeraMobile and PeraWatch are powered by the FDA-cleared Rothman Index, which uses predictive analytics based on a range of physiological measures including labs, vital signs, and nursing assessments. Sepsis ImmunoScore is the first FDA-authorized AI diagnostic for sepsis, leveraging AI/ML to analyze 22 diverse parameters from Electronic Health Records (EHRs).
PeraMobile and PeraWatch offer real-time patient acuity scoring, predictive analytics for patient deterioration, configurable warning states, push notifications, and visual dashboards of patient condition trends. Sepsis ImmunoScore generates a risk score and four discrete risk categories, predicting the risk of deterioration, such as length of stay, in-hospital mortality, ICU admission, mechanical ventilation, and vasopressor use, within 24 hours.
PeraMobile and PeraWatch are powered by the FDA-cleared Rothman Index. Sepsis ImmunoScore holds the distinction of being the first FDA-authorized AI diagnostic specifically for sepsis, approved via the De Novo pathway as an AI/ML Software as a Medical Device (SaMD).
PeraMobile and PeraWatch provide visual dashboards of patient condition trends. Sepsis ImmunoScore offers an intuitive display that explains how each of the 22 individual patient parameters contributes to the generated sepsis risk score, aiming for transparency in its AI-driven insights.

More Comparisons

eCARTv5 Clinical Deterioration Suite (“eCART”) vs Google Med-PaLM 2
ChatGPT vs Google Med-PaLM 2
When choosing between ChatGPT and Google Med-PaLM 2, physicians should consider their primary use case and desired level of medical…
Brainomix 360 e-CTA vs Google Med-PaLM 2
DeepXray vs Google Med-PaLM 2

More matchups featuring PeraMobile and PeraWatch or Sepsis ImmunoScore

Backers

Who funded each tool's parent company.

Sepsis ImmunoScore

AI Tool Finder
AI-powered search. Results may not be comprehensive.